AdvaMed® Joins Global Coalition to Promote Patient Access to Radiotherapy

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed®) has joined with several groups representing medical professionals, advocacy groups, international societies and the health care industry to form The Global Coalition for Radiotherapy (TGCR) to ensure cancer patients have access…

AdvaMed® Launches Center for Digital Health

WASHINGTON, DC. – The Advanced Medical Technology Association® (AdvaMed®) today announced the launch of its Center for Digital Health, a new advocacy platform designed to advance digital health and the contributions of…

AdvaMed® Welcomes APEC Advancing High-Standard Business Practices For Ethical Third-Party Relationships

TOKYO, Japan – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from Christopher L. White, chief operating officer, general counsel and secretary, following conclusion of the Asia-Pacific Economic…

AdvaMed® Statement on Administration’s COVID-19 Testing Policy for Employers

AdvaMed® released the following statement from AdvaMedDx® Executive Director Susan Van Meter on the testing policy regulation recently proposed by the Occupational Safety and Health Administration (OSHA) for employers with…

Committees & Working Groups

One of the best ways to become engaged in AdvaMed® is through our committees and 100+ working groups. Each policy area has a number of working groups that focus on…

Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish® Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer

MINNEAPOLIS (Dec. 2, 2025) – Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of prostate cancer, today announced that…

AdvaMed Digital Health Tech™

Powering the digital health revolution.

Carbon Medical Technologies’ BiomarC Fiducial Markers and BiomarC Restore Achieves EU MDR Certification

August 8, 2025 – Carbon Medical Technologies, Inc. (CMT), a manufacturer of implantable medical devices that utilize proprietary pyrolytic carbon coating technology, is proud to announce that both its BiomarC…

UroMems Receives Clearance from the FDA and the French ANSM for Initiating Landmark Pivotal Clinical Study of UroActive™ Smart Implant to Treat Male Stress Urinary Incontinence

GRENOBLE, France & MINNEAPOLIS, Minnesota (July 17, 2025) – UroMems, a global company developing innovative, mechatronics technology to treat stress urinary incontinence (SUI), received investigational device exemption (IDE) approval from…

Monteris Medical Announces Largest Prospective Publication to Date in JAMA Neurology on LITT for Epilepsy Cohort Using the NeuroBlate® System

WOBURN, Mass. (July 7, 2025) – Sirtex Medical (“Sirtex”), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food and Drug Administration (FDA) approved SIR-Spheres® Y-90 resin…